Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 1.00 |
| ▸ | MGLL | Q99685 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | GRK5 | P34947 | 1/20 | 0.42 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.42 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL28988835 | 0.89 | GAA (0.79) | GAAMGLLALDH1A1MEN1KMT2A | |
| Acetonitrile SCHEMBL29027185 | 0.87 | GAA (0.76) | GAAMGLLALDH1A1MEN1KMT2A | |
| SCHEMBL12631667 | 0.84 | GAA (0.72) | GAAMGLLALDH1A1MEN1KMT2A | |
| SCHEMBL10919078 | 0.84 | GAA (0.73) | GAAMGLLALDH1A1MEN1KMT2A | |
| Ethyl Acetate SCHEMBL30834713 | 0.77 | GAA (0.59) | GAAALDH1A1NPSR1HPGDNPC1 | |
| SCHEMBL11369341 | 0.75 | GAA (0.60) | GAAMGLLALDH1A1MEN1KMT2A | |
| SCHEMBL12631701 | 0.75 | ELANE (0.62) | GAAMGLLALDH1A1ELANENPC1 | |
| SCHEMBL13827444 | 0.75 | GAA (0.60) | GAAMGLLALDH1A1MEN1KMT2A | |
| SCHEMBL28943161 | 0.75 | GAA (0.60) | GAAMGLLELANEBCHEFAAH | |
| SCHEMBL14199135 | 0.75 | GAA (0.60) | GAAMGLLALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1078 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260140108-A1 | EXTRACTION ROD AND PREPARATION METHOD THEREOF, AND METHOD FOR DETECTING 25-HYDROXYVITAMIN D | INNOVATION CENTER OF YANGTZE RIVER DELTA ZJU (CN) | 2026-05-21 | — | — | US | claimed |
| US-12607640-B2 | Mass spectrometry of steroidal compounds in multiplex samples | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2026-04-21 | — | — | US | claimed |
| EP-4257428-B1 | HABITABLE MOTOR VEHICLE WITH FIVE SITTING PLACES PROVIDED WITH A TABLE | TRIGANO VAN (IT) | 2026-04-01 | — | — | EP | claimed |
| EP-4609204-A1 | NANOPORE-BASED ANALYSIS OF PROTEINS | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2025-09-03 | — | — | EP | claimed |
| EP-4256347-B1 | DETECTION OF AN ANALYTE OF INTEREST BY CROSS SPRAY ESI MASS SPECTROMETRY | HOFFMANN LA ROCHE (CH) | 2025-07-16 | — | — | EP | claimed |
| US-20250216404-A1 | VITAMIN D METABOLITE DETERMINATION UTILIZING MASS SPECTROMETRY FOLLOWING DERIVATIZATION | QUEST DIAGNOSTICS INVEST LLC (US) | 2025-07-03 | — | — | US | claimed |
| CN-120009442-A | Method for quantitatively detecting derivatized vitamin E by high performance liquid chromatography-tandem mass spectrometry and application thereof | 山东英盛生物技术有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119989456-A | Vehicle-bridge parameter synchronous inversion identification method based on depth time sequence model | 东南大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119470730-B | Preservation reagent, preservation method and detection method for fat-soluble vitamins D2, D3 and A, E in peripheral blood | 江苏硕世生物科技股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119881180-A | Vitamin D mass spectrum detection method based on antibody immune enrichment technology | 浙江大学长三角智慧绿洲创新中心 | 2025-04-25 | — | — | CN | claimed |
| EP-0338425-A1 | Modified polyphenylene ethers | BASF Aktiengesellschaft (DE) | 1989-10-25 | — | — | EP | claimed |
| EP-0337305-A1 | Process for the preparation of 1-alpha,25-dihydroxy-vitamin D2 and the 24-epimer thereof | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1989-10-18 | — | — | EP | claimed |
| US-4758383-A | Ergosta-1,5,7,22-tetraen-3β-ol and its use as an intermediate for 1α-hydroxy vitamin D2 | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1988-07-19 | — | — | US | claimed |
| EP-0270867-A1 | Steroid derivatives and processes of preparing same | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1988-06-15 | — | — | EP | claimed |
| EP-0070588-B1 | METHOD OF PREPARING 1-ALPHA-HYDROXYVITAMIN D AND 1-ALPHA-HYDROXY-PREVITAMIN D COMPOUNDS, AND ADDUCT OF A PREVITAMIN D OR TACHYSTEROL COMPOUND WITH A SUITABLE DIENOPHILE | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1986-05-07 | — | — | EP | claimed |
| US-4539153-A | Method of preparing 1 α-hydroxyvitamin D and 1 α-hydroxyprevitamin D compounds, and adducts of a previtamin D or tachysterol compound with a suitable dienophile | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1985-09-03 | — | — | US | claimed |
| EP-0070588-A1 | Method of preparing 1-alpha-hydroxyvitamin D and 1-alpha-hydroxy-previtamin D compounds, and adduct of a previtamin D or tachysterol compound with a suitable dienophile | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1983-01-26 | — | — | EP | claimed |
| US-4217288-A | Anti-vitamin D compounds | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1980-08-12 | — | — | US | claimed |
| US-4105660-A | Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one | MERCK & CO., INC. (US) | 1978-08-08 | — | — | US | claimed |
| US-4088645-A | O,O-Dialkylphosphoryloxy-2,3,5,8-tetrahydro-1H-s-triazolo[1,2a]pyridazine-1,3-diones | HOFFMANN-LA ROCHE INC. (US) | 1978-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12607640-B2 | Mass spectrometry of steroidal compounds in multiplex samples | CYP24A1, CYP2R1, SRD5A1 | GAA 4777/4885MGLL 3707/4885ALDH1A1 1445/4885 |
| US-20260140108-A1 | EXTRACTION ROD AND PREPARATION METHOD THEREOF, AND METHOD FOR DETECTING 25-HYDROXYVITAMIN D | VDR, CYP24A1, GC | GAA 2683/4885MGLL 4540/4885ALDH1A1 2724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.